CVC-led consortium closes in on £1 billion-plus investment in Standard Life's pension risk transfer business
A CVC Capital Partners-led consortium is nearing a deal to invest more than £1 billion in the pension risk transfer unit of Standard Life, according to reporting in the Financial Times. The transaction would represent one of the largest PE-backed plays into the UK bulk annuity (pension buy-in and buyout) market in recent memory — a sector that has attracted intense investor interest as UK defined benefit (DB) schemes accelerate de-risking following Mansion House reforms and a surge in funding surpluses driven by higher gilt yields. The deal structure involves a consortium investment rather than a straightforward acquisition, reflecting the regulatory complexity of taking a stake in an insurance-regulated entity: any change of control in a PRA-authorised insurer requires regulatory approval, and minority investment structures are often used to thread that needle. Standard Life, now part of Phoenix Group, operates one of the UK's largest bulk annuity platforms — a market that wrote a record £50 billion-plus of premiums in 2024. The strategic logic is compelling: DB pension schemes are queuing to offload their longevity and investment risk, creating a near-captive pipeline of long-duration, highly-rated insurance liabilities that PE-backed capital finds attractive as a yield-generating alternative to conventional buyouts. With deal volumes expected to remain elevated through 2026 and 2027, investors are seeking upstream exposure to the platforms processing that flow rather than simply competing for individual scheme transactions.
Why this matters
A £1 billion-plus consortium investment in a PRA-regulated bulk annuity platform activates a broad sweep of practice areas simultaneously: M&A (deal structuring and consortium documentation), insurance regulatory (PRA change-of-control approval under FSMA 2000 Part XII), and financial services (capital adequacy and Solvency UK implications for the platform). The 'why now' trigger is the continued DB pension de-risking wave — funded by gilt-driven surpluses — which has inflated demand for bulk annuity capacity faster than existing platforms can supply it, making upstream platform investment economically rational. Firms with strong insurance M&A and PRA regulatory practices are best placed to advise on a transaction of this type; the consortium structure also generates significant fund finance and co-investment documentation work. The deal signals that PE's appetite for exposure to the UK pension risk transfer market is moving from secondary observation to active platform ownership.
On the Ground
A trainee on this matter would assist with drafting the PRA Part XII regulatory notification and coordinating submissions to the regulator alongside senior associates. They would also index due diligence materials on the target's annuity book — reviewing Solvency UK capital reports, longevity reinsurance treaties, and investment mandate documentation — and prepare SPA schedule summaries for partner review.
Interview prep
Soundbite
PE capital flowing into bulk annuity platforms captures the de-risking wave upstream — before individual scheme transactions even reach pricing.
Question you might get
“What regulatory approvals would a PE consortium need before completing an investment in a PRA-authorised bulk annuity insurer, and which aspects of that process are most likely to cause delay?”
Full answer
A CVC-led consortium is reported to be closing in on a £1 billion-plus stake in Standard Life's pension risk transfer business. This matters because pension risk transfer — where insurers take on DB pension scheme liabilities via buy-ins and buyouts — is one of the UK's fastest-growing financial markets, with annual deal volumes now exceeding £50 billion. Rather than competing in individual auctions, this consortium is acquiring platform-level exposure to the entire pipeline. The structural driver is the combination of Mansion House de-risking incentives and gilt-driven funding surpluses that have made DB schemes eager and able to transact. This suggests PE firms will increasingly seek regulated-platform stakes rather than product-level positions — generating complex insurance M&A and Solvency UK advisory mandates for firms with deep PRA regulatory practices.
My notes
saved